291 related articles for article (PubMed ID: 2226434)
1. Geometry of binding of the benzamidine- and arginine-based inhibitors N alpha-(2-naphthyl-sulphonyl-glycyl)-DL-p-amidinophenylalanyl-pipe ridine (NAPAP) and (2R,4R)-4-methyl-1-[N alpha-(3-methyl-1,2,3,4-tetrahydro-8- quinolinesulphonyl)-L-arginyl]-2-piperidine carboxylic acid (MQPA) to human alpha-thrombin. X-ray crystallographic determination of the NAPAP-trypsin complex and modeling of NAPAP-thrombin and MQPA-thrombin.
Bode W; Turk D; Stürzebecher J
Eur J Biochem; 1990 Oct; 193(1):175-82. PubMed ID: 2226434
[TBL] [Abstract][Full Text] [Related]
2. Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics.
Brandstetter H; Turk D; Hoeffken HW; Grosse D; Stürzebecher J; Martin PD; Edwards BF; Bode W
J Mol Biol; 1992 Aug; 226(4):1085-99. PubMed ID: 1518046
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibition of thrombin by (2R,4R)-4-methyl-1-[N2-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl++ +) sulfonyl]-l-arginyl)]-2-piperidinecarboxylic acid.
Kikumoto R; Tamao Y; Tezuka T; Tonomura S; Hara H; Ninomiya K; Hijikata A; Okamoto S
Biochemistry; 1984 Jan; 23(1):85-90. PubMed ID: 6691968
[TBL] [Abstract][Full Text] [Related]
4. Rational design of hirulog-type inhibitors of thrombin.
Egner U; Hoyer GA; Schleuning WD
J Comput Aided Mol Des; 1994 Oct; 8(5):479-90. PubMed ID: 7876896
[TBL] [Abstract][Full Text] [Related]
5. Geometry of binding of the N alpha-tosylated piperidides of m-amidino-, p-amidino- and p-guanidino phenylalanine to thrombin and trypsin. X-ray crystal structures of their trypsin complexes and modeling of their thrombin complexes.
Turk D; Stürzebecher J; Bode W
FEBS Lett; 1991 Aug; 287(1-2):133-8. PubMed ID: 1879520
[TBL] [Abstract][Full Text] [Related]
6. The X-ray crystal structure of thrombin in complex with N alpha-2-naphthylsulfonyl-L-3-amidino-phenylalanyl-4-methylpiperidide: the beneficial effect of filling out an empty cavity.
Bergner A; Bauer M; Brandstetter H; Stürzebecher J; Bode W
J Enzyme Inhib; 1995; 9(1):101-10. PubMed ID: 8568562
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of trypsin and thrombin by amino(4-amidinophenyl)methanephosphonate diphenyl ester derivatives: X-ray structures and molecular models.
Bertrand JA; Oleksyszyn J; Kam CM; Boduszek B; Presnell S; Plaskon RR; Suddath FL; Powers JC; Williams LD
Biochemistry; 1996 Mar; 35(10):3147-55. PubMed ID: 8605148
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of inhibitors derived from 3-amidinophenylalanine.
Stürzebecher J; Prasa D; Wikström P; Vieweg H
J Enzyme Inhib; 1995; 9(1):87-99. PubMed ID: 8568569
[TBL] [Abstract][Full Text] [Related]
9. Similarity and dissimilarity in the stereogeometry of the active sites of thrombin, trypsin, plasmin and glandular kallikrein.
Hijikata-Okunomiya A; Okamoto S; Kikumoto R; Tamao Y; Ohkubo K; Tezuka T; Tonomura S; Matsumoto O
Thromb Res; 1987 Mar; 45(5):451-62. PubMed ID: 2954262
[TBL] [Abstract][Full Text] [Related]
10. Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.
Banner DW; Hadváry P
J Biol Chem; 1991 Oct; 266(30):20085-93. PubMed ID: 1939071
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationships of potent thrombin inhibitors: piperazides of 3-amidinophenylalanine.
Stürzebecher J; Prasa D; Hauptmann J; Vieweg H; Wikström P
J Med Chem; 1997 Sep; 40(19):3091-9. PubMed ID: 9301673
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterisation of novel thrombin inhibitors based on 4-amidinophenylalanine.
Reers M; Koschinsky R; Dickneite G; Hoffmann D; Czech J; Stüber W
J Enzyme Inhib; 1995; 9(1):61-72. PubMed ID: 8568567
[TBL] [Abstract][Full Text] [Related]
13. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of new NAPAP-analogs.
Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
J Enzyme Inhib Med Chem; 2002 Apr; 17(2):241-9. PubMed ID: 12420761
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological activity of novel rigid amidino-phenylalanine derivatives as inhibitors of thrombin.
Mack H; Pfeiffer T; Hornberger W; Böhm HJ; Höffken HW
J Enzyme Inhib; 1995; 9(1):73-86. PubMed ID: 8568568
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of two new bifunctional nonsubstrate type thrombin inhibitors complexed with human alpha-thrombin.
Féthière J; Tsuda Y; Coulombe R; Konishi Y; Cygler M
Protein Sci; 1996 Jun; 5(6):1174-83. PubMed ID: 8762149
[TBL] [Abstract][Full Text] [Related]
17. Human alpha-thrombin inhibition by the active site titrant N alpha-(N,N-dimethylcarbamoyl)-alpha-azalysine p-nitrophenyl ester: a comparative kinetic and X-ray crystallographic study.
Nardini M; Pesce A; Rizzi M; Casale E; Ferraccioli R; Balliano G; Milla P; Ascenzi P; Bolognesi M
J Mol Biol; 1996 May; 258(5):851-9. PubMed ID: 8637015
[TBL] [Abstract][Full Text] [Related]
18. Crystallographic structure of a peptidyl keto acid inhibitor and human alpha-thrombin.
Håkansson K; Tulinsky A; Abelman MM; Miller TA; Vlasuk GP; Bergum PW; Lim-Wilby MS; Brunck TK
Bioorg Med Chem; 1995 Aug; 3(8):1009-17. PubMed ID: 7582975
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of new NAPAP-analogs.
Steinmetzer T; Schweinitz A; Künzel S; Wikström P; Hauptmann J; Stürzebecher J
J Enzyme Inhib; 2001; 16(3):241-9. PubMed ID: 11697044
[TBL] [Abstract][Full Text] [Related]
20. Biochemical and crystallographic characterization of homologous non-peptidic thrombin inhibitors having alternate binding modes.
Strickland CL; Fevig JM; Galemmo RA; Wells BL; Kettner CA; Weber PC
Acta Crystallogr D Biol Crystallogr; 1998 Nov; 54(Pt 6 Pt 2):1207-15. PubMed ID: 10089499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
